Project Description
Covid-19 Oral Vaccine
HOW WE TACKLED THE BRIEF GIVEN TO US
Brief
The new coronavirus, first called 2019-nCoV and officially renamed as SARS-CoV2 (the virus) and COVID-19 (the disease), belongs to the family of coronavirus, which owe the name to crown-like spikes on their surface. Most described coronavirus are found in birds or mammals, particularly bats. Many efforts have been made to develop vaccines to prevent coronavirus diseases. Due to the global pandemic of this disease, vaccines made can not prevent this epidemic quickly, and on the other hand, due to the short period of immunity that vaccines produced so far can not be less than 6 months, must half or more than half of the world’s population Vaccinated to prevent the pandemic of this disease. There is a need for a vaccine that, in addition to easy access and use without the need for medical staff, can be prevented by mass production in the shortest possible time.
Deliverables
The goal is to achieve a high-speed vaccine to provide to the international community to break the pandemic chain, to create immunity for a long time between 3 to 5 years, a vaccine with very easy use without the need for healthcare staff to inject into different people, the least side effect, Used by all people with any underlying disease and age, no need for a cold chain to get it to people anywhere in the world
Long-term immunity
Least Side Effect
Easy to Use
Can be used for all ages and people with underlying diseases
Easy and fast mass production
Results
We made our vaccine and we are in the pre-clinical stage to evaluate parameters of immunity and some other parameters.
Ready to Talk?
DO YOU HAVE A BIG IDEA WE CAN HELP WITH?
Leave A Comment